**Author details**

María Pilar Vaquero1 , Ángel García-Quismondo2 , Francisco J. del Cañizo<sup>3</sup> \* and Francisco J. Sánchez-Muniz2

\*Address all correspondence to: frasan@ucm.es

1 Department of Metabolism and Nutrition, Institute of Food Science, Technology and Nutrition, Spanish National Research Council (ICTAN-CSIC), Madrid, Spain

2 Department of Nutrition, Universidad Complutense de Madrid, Madrid, Spain

3 Servicio de Endocrinología, Hospital Infanta Leonor, Madrid, Spain

### **References**

syndrome has been related to liver fat accumulation and visceral adiposity [89]. Whether hepcidin resistance is linked to insulin resistance should be a matter of further research.

Our data in an ample sample of adults diagnosed with T2DM suggest that body iron stores, evaluated as serum ferritin, are clearly related with some key markers of the so-called lipidic triad of the T2DM (high triglyceride and low HDL-cholesterol levels together with the presence of small and dense LDL particles) which also is in the frame of the dysmetabolic iron overload

This study was partially supported by the Spanish project AGL2014-53207-C2-2-R. We also acknowledge type 2 diabetes mellitus patients from de DICARIVA study for their voluntary

participation and the Infanta Leonor Hospital of Madrid (Spain).

CVD cardiovascular diseases DMT1 divalent metal transporter

IDA iron deficiency anemia

NTBI non-transferrin-bound iron ROS reactive oxygen species T2DM type 2 diabetes mellitus TfR1 transferrin receptor

FPN ferroportin

, Ángel García-Quismondo2

HDL-cholesterol cholesterol transported by high density lipoproteins

Nutrition, Spanish National Research Council (ICTAN-CSIC), Madrid, Spain

3 Servicio de Endocrinología, Hospital Infanta Leonor, Madrid, Spain

2 Department of Nutrition, Universidad Complutense de Madrid, Madrid, Spain

1 Department of Metabolism and Nutrition, Institute of Food Science, Technology and

, Francisco J. del Cañizo<sup>3</sup>

\* and Francisco

syndrome.

**Acknowledgements**

110 Recent Trends in Cardiovascular Risks

**Abbreviations**

**Author details**

María Pilar Vaquero1

\*Address all correspondence to: frasan@ucm.es

J. Sánchez-Muniz2


[27] Arezes J, Nemeth E. Hepcidin and iron disorders: New biology and clinical approaches. International Journal of Laboratory Hematology. 2015;**37**(Suppl 1):92-98

[14] Krause A, Neitz S, Mägert H-J, Schulz A, Forssmann W-G, Schulz-Knappe P, et al. LEAP-1, a novel highly disulfide-bonded human peptide, exhibits antimicrobial activity. FEBS

[15] Park CH, Valore EV, Waring AJ, Ganz T. Hepcidin, a urinary antimicrobial peptide synthesized in the liver. The Journal of Biological Chemistry. 2001;**276**(11):7806

[16] Schmidt PJ. Regulation of iron metabolism by hepcidin under conditions of inflamma-

[17] Sarriá B, López-Parra AM, Navas-Carretero S, Pérez-Granados AM, Baeza C, Arroyo-Pardo E, et al. Hepcidin, transferrin (exon 7), and hemochromatosis genotyping suggests that haplotype block analysis is the best strategy for predicting iron deficiency pheno-

[18] Roetto A, Papanikolaou G, Politou M, Alberti F, Girelli D, Christakis J, et al. Mutant antimicrobial peptide hepcidin is associated with severe juvenile hemochromatosis. Nature

[19] Blanco-Rojo R, Baeza-Richer C, Lopez-Parra AM, Perez-Granados AM, Brichs A, Bertoncini S, et al. Four variants in transferrin and HFE genes as potential markers of iron deficiency anemia risk: An association study in menstruating women. Nutrition

[20] Blanco-Rojo R, Bayele HK, Srai SK, Vaquero MP. Intronic SNP rs3811647 of the human transferrin gene modulates its expression in hepatoma cells. Nutrición Hospitalaria.

[21] Baeza-Richer C, Arroyo-Pardo E, Blanco-Rojo R, Toxqui L, Remacha A, Vaquero MP, et al. Genetic contribution to iron status: SNPs related to iron deficiency anemia and fine mapping of CACNA2D3 calcium channel subunit. Blood Cells, Molecules, and Diseases.

[22] Baeza-Richer C, Blanco-Rojo R, Lopez-Parra AM, Brichs A, Bertoncini S, Perez-Granados AM, et al. Identification of a novel quantitative trait nucleotype related to iron status in

[23] Sarria B, Navas-Carretero S, Lopez-Parra AM, Perez-Granados AM, Arroyo-Pardo E, Roe MA, et al. The G277S transferrin mutation does not affect iron absorption in iron

[24] Blanco-Rojo R. Dietary, genetic and physiological risk factors for iron deficiency anemia, and efficacy of a functional food in iron deficient women [thesis]. Madrid: Complutense

[26] Liu J, Sun B, Yin H, Liu S. Hepcidin: A promising therapeutic target for iron disorders: A

[25] Ganz T. Hepcidin and iron regulation, 10 years later. Blood. 2011;**117**(17):4425-4433

a calcium channel gene. Disease Markers. 2013;**34**(2):121-129

systematic review. Medicine. 2016;**95**(14):e3150

deficient women. European Journal of Nutrition. 2007;**46**(1):57-60

tion. The Journal of Biological Chemistry. 2015;**290**(31):18975-18983

type in women. Nutrition Research. 2007;**27**(11):672-678

Letters. 2000;**480**(2-3):147-150

112 Recent Trends in Cardiovascular Risks

Genetics. 2003;**33**(1):21-22

2012;**27**(6):2142-2145

2015;**55**(4):273-280

University; 2012

and Metabolism(London). 2011;**8**:69


[55] Remacha ÁF, Arrizabalaga B, Villegas A, Durán MS, Hermosín L, de Paz R, et al. Evolution of iron overload in patients with low-risk myelodysplastic syndrome: Iron chelation therapy and organ complications. Annals of Hematology. 2015;**94**(5):779-787

[41] Corti M-C, Guralnik JM, Salive ME, Ferrucci L, Pahor M, Wallace RB, et al. Serum iron level, coronary artery disease, and all-cause mortality in older men and women.

[42] Vaquero MP, Sanchez-Muniz FJ, Carbajal A, Garcia-Linares MC, Garcia-Fernandez MC, Garcia-Arias MT. Mineral and vitamin status in elderly persons from Northwest Spain consuming an Atlantic variant of the Mediterranean diet. Annals of Nutrition &

[43] Iribarren C, Sempos CT, Eckfeldt JH, Folsom AR. Lack of association between ferritin level and measures of LDL oxidation: The ARIC study. Atherosclerosis Risk in

[44] Moore M, Folsom AR, Barnes RW, Eckfeldt JH. No association between serum ferritin and asymptomatic carotid atherosclerosis. The Atherosclerosis Risk in Communities

[45] Moore KJ, Sheedy FJ, Fisher EA. Macrophages in atherosclerosis: A dynamic balance.

[46] Hosseini B, Saedisomeolia A, Skilton MR. Association between micronutrients intake/ status and carotid intima media thickness: A systematic review. Journal of the Academy

[47] Ahluwalia N, Genoux A, Ferrieres J, Perret B, Carayol M, Drouet L, et al. Iron status is associated with carotid atherosclerotic plaques in middle-aged adults. Journal of

[48] Kopriva D, Kisheev A, Meena D, Pelle S, Karnitsky M, Lavoie A, et al. The nature of iron deposits differs between symptomatic and asymptomatic carotid atherosclerotic

[49] Kautz L, Gabayan V, Wang X, Wu J, Onwuzurike J, Jung G, et al. Testing the iron hypoth-

[50] Engberink MF, Geleijnse JM, Durga J, Swinkels DW, de Kort WL, Schouten EG, et al. Blood donation, body iron status and carotid intima-media thickness. Atherosclerosis.

[51] Hoekstra KA, Godin DV, Cheng KM. Protective role of heme oxygenase in the blood vessel wall during atherogenesis. Biochemistry and Cell Biology. 2004;**82**(3):351-359

[52] Jeney V, Balla J, Yachie A, Varga Z, Vercellotti GM, Eaton JW, et al. Pro-oxidant and cyto-

[53] Morita T. Heme oxygenase and atherosclerosis. Arteriosclerosis Thrombosis and

[54] Mascitelli L, Goldstein MR. Hereditary hemochromatosis, iron, hepcidin, and coronary

toxic effects of circulating heme. Blood. 2002;**100**(3):879-887

heart disease. Medical Hypotheses. 2014;**82**(3):402-403

esis in a mouse model of atherosclerosis. Cell Reports. 2013;**5**(5):1436-1442

(ARIC) Study. American Journal of Epidemiology. 1995;**141**(8):719-723

American Journal of Cardiology. 1997;**79**(2):120-127

Communities. Atherosclerosis. 1998;**139**(1):189-195

Nature Reviews Immunology. 2013;**13**(10):709-721

of Nutrition and Dietetics. 2016;**117**:69-82

plaques. PLoS One. 2015;**10**(11):e0143138

Vascular Biology. 2005;**25**(9):1786-1795

Nutrition. 2010;**140**(4):812-816

2008;**196**(2):856-862

Metabolism. 2004;**48**(3):125-133

114 Recent Trends in Cardiovascular Risks


[83] Coppack SW, Evans RD, Fisher RM, Frayn KN, Gibbons GF, Humphreys SM, et al. Adipose tissue metabolism in obesity: Lipase action in vivo before and after a mixed meal. Metabolism: Clinical and Experimental. 1992;**41**(3):264-272

[68] Tiedge M, Lortz S, Drinkgern J, Lenzen S. Relation between antioxidant enzyme gene expression and antioxidative defense status of insulin-producing cells. Diabetes.

[69] Huang J, Jones D, Luo B, Sanderson M, Soto J, Abel ED, et al. Iron overload and diabetes risk: A shift from glucose to fatty acid oxidation and increased hepatic glucose production in a mouse model of hereditary hemochromatosis. Diabetes. 2011;**60**(1):80-87 [70] Swaminathan S, Fonseca VA, Alam MG, Shah SV. The role of iron in diabetes and its

[71] Rajpathak S, Ma J, Manson J, Willett WC, Hu FB. Iron intake and the risk of type 2 diabetes in women: A prospective cohort study. Diabetes Care. 2006;**29**(6):1370-1376

[72] Hua NW, Stoohs RA, Facchini FS. Low iron status and enhanced insulin sensitivity in

[73] Ascherio A, Rimm EB, Giovannucci E, Willett WC, Stampfer MJ. Blood donations and

[74] Valenti L, Fracanzani AL, Dongiovanni P, Rovida S, Rametta R, Fatta E, et al. A randomized trial of iron depletion in patients with nonalcoholic fatty liver disease and hyperfer-

[75] O'Brien J, Powell LW. Non-alcoholic fatty liver disease: Is iron relevant? Hepatology

[76] Laine F, Ruivard M, Loustaud-Ratti V, Bonnet F, Cales P, Bardou-Jacquet E, et al. Metabolic and hepatic effects of bloodletting in dysmetabolic iron overload syndrome: A randomized controlled study in 274 patients. Hepatology (Baltimore, Md). 2017;**65**(2):465-474

[77] Carmena R, Ascaso JF. Global therapy of diabetic dyslipidemia: Benefits and new thera-

[78] Taskinen MR. Diabetic dyslipidaemia: From basic research to clinical practice.

[79] Haffner SM, Valdez RA, Hazuda HP, Mitchell BD, Morales PA, Stern MP. Prospective analysis of the insulin-resistance syndrome (syndrome X). Diabetes. 1992;**41**(6):715-722

[80] Garcia-Quismondo A. Proteína C reactiva, índice de conicidad y factores de riesgo cardiovascular en pacientes con diabetes tipo 2 [Thesis]. Madrid: Complutense University;

[81] Boizel R, Benhamou PY, Lardy B, Laporte F, Foulon T, Halimi S. Ratio of triglycerides to HDL cholesterol is an indicator of LDL particle size in patients with type 2 diabetes and

[82] Rainwater DL. Lipoprotein correlates of LDL particle size. Atherosclerosis. 2000;**148**(1):

normal HDL cholesterol levels. Diabetes Care. 2000;**23**(11):1679-1685

lacto-ovo vegetarians. The British Journal of Nutrition. 2007;**86**(04):515

risk of coronary heart disease in men. Circulation. 2001;**103**(1):52-57

ritinemia. World Journal of Gastroenterology. 2014;**20**(11):3002-3010

peutic approaches. Medicina Clinica. 2010;**134**(9):406-411

1997;**46**(11):1733-1742

116 Recent Trends in Cardiovascular Risks

International. 2012;**6**(1):332-341

Diabetologia. 2003;**46**(6):733-749

2016

151-158

complications. Diabetes Care. 2007;**30**(7):1926-1933

